Due to the copyrights of the publishing party, some of the links lead to websites that require payment for the article. However, the article’s abstract is given in full.

Drug treatment of congenital CMV:

Hematologic Adverse Events Associated with Prolonged Valganciclovir Treatment in Congenital Cytomegalovirus Infection
Bilavsky Efraim, Osovsky Micky, Amir Jacob, Yarden-Bilavsky Havatzelet, Pardo Joseph, Yacobovich Joanne, Ziv Liron
The Pediatric Infectious Disease Journal April 19,2018- Volume Publish Ahead of Print Issue
Doi: 10.1097/inf.0000000000002079

Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss
.Yehonatan Pasternak, Liron Ziv, Joseph Attias, Jacob Amir, Efraim Bilavsky
The Journal of Pediatrics 2018

Valganciclovir for symptomatic congenital cytomegalovirus disease
Kimberlin DW, Jester PM, Sánchez PJ, et al
. N Engl J Med. 2015;372:933-943

Treatment of Late-Onset Hearing  Loss in Infants With Congenital Cytomegalovirus Infection (Requires payment)
Jacob Amir, MD1,2, Joseph Attias, DSc1, and Joseph Pardo, MD2,3
Clin Pediatr (Phila). 2014 May;53(5):444-8. doi: 10.1177/0009922813510204. Epub 2013 Nov 25

In utero treatment of congenital cytomegalovirus infection with valacyclovir
in a multicenter, open-label, phase II study

Leruez-Ville M1, Ghout I2, Bussières L3, Stirnemann J4, Magny JF5, Couderc S6, Salomon LJ4, Guilleminot T1, Aegerter P2, Benoist G7, Winer N8, Picone O9, Jacquemard F10, Ville Y11

Am J Obstet Gynecol. 2016 Oct;215(4):462.e1-462.e10. doi: 10.1016/j.ajog.2016.04.003. Epub 2016 Apr 13

Skip to content